Abionyx Pharma (ABNX.FP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [Euronext FR]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [Euronext FR]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Sales | 0 | 174 | 0 | 0 | 0 |
| Gross Profit | 0 | 174 | 0 | 0 | 0 |
| Operating Expenses | 2,420 | 7,226 | 6,371 | 23,657 | 15,177 |
| Operating Income | -2,420 | -7,052 | -6,371 | -23,657 | -15,177 |
| Interest Expense | 350 | 0 | 167 | 1,257 | 1,217 |
| Other Income | 4,658 | 748 | 1,562 | 38 | -244 |
| Pre-tax Income | 1,888 | -6,304 | -4,976 | -24,876 | -16,638 |
| Income Tax | 38 | 1 | 2 | -5 | 0 |
| Net Income Continuous | 1,850 | -6,305 | -4,978 | -24,871 | -16,638 |
| Net Income | $1,849 | $-6,305 | $-4,978 | $-24,871 | $-16,638 |
| EPS Basic Total Ops | 0.09 | -0.34 | -0.27 | -1.39 | -1.00 |
| EPS Basic Continuous Ops | 0.09 | -0.34 | -0.27 | -1.39 | -1.00 |
| EPS Diluted Total Ops | 0.09 | -0.34 | -0.27 | -1.39 | -1.00 |
| EPS Diluted Continuous Ops | 0.09 | -0.34 | -0.27 | -1.39 | -1.00 |
| EBITDA(a) | $2,251 | $-5,549 | $-4,766 | $-23,571 | $-15,365 |